ADAP
Adaptimmune Therapeutics Plc · HEALTHCARE
No insider bought or sold Adaptimmune Therapeutics Plc in the last 12 months
ADAP over the last year
Prices for ADAP aren't in yet.
ADAP after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
76 insider filings since 2017, newest first
Adrian Rawcliffe · CEO
Garry E Menzel · Director
Adrian Rawcliffe · CEO
Cintia Piccina · Chief Commercial Officer
Adrian Rawcliffe · CEO
Adrian Rawcliffe · CEO
Adrian Rawcliffe · CEO
Adrian Rawcliffe · CEO
William C Bertrand Jr · COO
John Lunger · Chief Patient Supply Officer
Helen Katrina Tayton-Martin · Chief Business Officer
Adrian Rawcliffe · CEO
James Noble · Director
Ali Behbahani · Director
Peter W. Sonsini · 10% owner
Scott D Sandell · 10% owner
David M Mott · Director and 10% owner
Anthony A. Florence Jr. · 10% owner
Forest Baskett · 10% owner
Helen Katrina Tayton-Martin · Chief Business Officer
James Noble · Director
Lawrence M Alleva · Director
Gwendolyn Knowlton Binder-Scholl · CTO
Ali Behbahani · Director
Ravi Viswanathan · 10% owner
Peter W. Sonsini · 10% owner
Scott D Sandell · 10% owner
David M Mott · Director and 10% owner
Patrick J Kerins · 10% owner
Anthony A. Florence Jr. · 10% owner
Forest Baskett · 10% owner
Peter J Barris · 10% owner
M James Barrett · 10% owner
New Enterprise Associates 14, L.P. · 10% owner
Gwendolyn Knowlton Binder-Scholl · CTO
Peter A. Thompson · Director
Orbimed Advisors LLC · Director
Peter A. Thompson · Director
Orbimed Advisors LLC · Director
Peter A. Thompson · Director
Orbimed Advisors LLC · Director
Peter A. Thompson · Director
Orbimed Advisors LLC · Director
Ravi Viswanathan · 10% owner
Peter W. Sonsini · 10% owner
Scott D Sandell · 10% owner
David M Mott · Director and 10% owner
Patrick J Kerins · 10% owner
Anthony A. Florence Jr. · 10% owner
Forest Baskett · 10% owner
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.